Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. Signal., 14 February 2012
[DOI: 10.1126/scisignal.2001963]

Supplementary Materials for:

Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist

William S. Bowen, Laurie A. Minns, David A. Johnson, Thomas C. Mitchell, Melinda M. Hutton, Jay T. Evans*

*To whom correspondence should be addressed. E-mail: jay.t.evans{at}gskbio.com

This PDF file includes:

  • Fig. S1. Comparison of the production of MyD88- and TRIF-dependent cytokines and chemokines by human monocytes treated with CRX-527, CRX-547, Re595 LPS, or sMLA.
  • Fig. S2. CRX-547 stimulates the production of lower amounts of IL-1β by human PBMCs than does CRX-527.

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 300 KB

Citation: W. S. Bowen, L. A. Minns, D. A. Johnson, T. C. Mitchell, M. M. Hutton, J. T. Evans, Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist. Sci. Signal. 5, ra13 (2012).

© 2012 American Association for the Advancement of Science

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882